Articles

Back to the Summit Resources

General MCAS

Dr Afrin’s Consensus 2 article. (Dr Kelly is a co-author, along with many others)

Characterization of Mast Cell Activation Syndrome

A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms

Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders? Dr Theoharides

MCAS and GI

MCAS: a primer for the gastroenterologist – Dr leonard Weinstock. 

MCAS and COVID

Mast cell activation symptoms are prevalent in Long-COVID

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome

Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue

MCAS, POTS (postural orthostatic tachycardia syndrome, and EDS (Ehlers Danlos Syndrome)

Some cases of hypermobile Ehlers-Danlos syndrome may be rooted in mast cell activation syndrome

The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome

Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On

Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment

Burning Mouth Syndrome and MCAS

Burning mouth syndrome and mast cell activation disorder

Chronic Pelvic Pain, Painful Menses and MCAS

Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding

HPV vaccination

Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?

Interstitial cystitis and MCAS

None of the articles are available in full text

MCAS and Autism

Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder

Mast cell activation and autism

Dr Theoharides’ website

MCAS and Brain Fog

Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin

Cell Danger Response

Metabolic features of chronic fatigue syndrome

Mitochondrial and metabolic features of salugenesis and the healing cycle